Analyst consensus rating
TG Therapeutics Analyst Rating: Strong Buy
Direct answer
TG Therapeutics's consensus rating is Strong Buy.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $69.71.
Forecast evidence checked September 8, 2026.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $55.69
- Average price target
- $69.71
- High price target
- $86.00
- Low price target
- $21.00
- Low target gap
- -62.3%
- Target upside
- +25.2%
- High target gap
- +54.4%
- Target range width
- 116.7%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- September 8, 2026
- Valid through
- September 15, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for TG Therapeutics?
TG Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $69.71.
How far are TG Therapeutics's low and high targets from the recorded price?
The low target implies -62.3%, while the high target implies +54.4%.
How many analysts are included in TG Therapeutics's consensus?
The verified consensus includes 7 analysts.
How is TG Therapeutics's target upside or downside calculated?
The average target of $69.71 is divided by the recorded price of $55.69, then one is subtracted to produce +25.2%. This does not guarantee a future return.
When was TG Therapeutics's analyst forecast verified?
The data was verified on 2026-09-08. The dataset is valid through 2026-09-15.